SAB Biotherapeutics shares owned by UBS Group
Quarter-by-quarter ownership of SAB Biotherapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in SAB Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including SAB Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in SAB Biotherapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $344 | 500 | 0.69 |
2023-03-31 | $2.9k | 6.7k | 0.44 |
2022-12-31 | $4.1k | 6.9k | 0.59 |
2022-09-30 | $0 | 1.5k | 0.00 |
2022-06-30 | $1.0k | 1.0k | 1.00 |
2022-03-31 | $6.9k | 1.4k | 4.91 |
2021-12-31 | $49k | 6.0k | 8.18 |